Asset Details
Do you wish to reserve the book?
PD233 Does Patient Input Add Value To Healthcare Decision-Making? A Two-Year Reflection On Patient Involvement Processes In Singapore
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
PD233 Does Patient Input Add Value To Healthcare Decision-Making? A Two-Year Reflection On Patient Involvement Processes In Singapore
Do you wish to request the book?
PD233 Does Patient Input Add Value To Healthcare Decision-Making? A Two-Year Reflection On Patient Involvement Processes In Singapore
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
PD233 Does Patient Input Add Value To Healthcare Decision-Making? A Two-Year Reflection On Patient Involvement Processes In Singapore
2025
Overview
IntroductionIn 2022, the Agency for Care Effectiveness (ACE) co-developed patient involvement processes with local patient organizations to enable patients and caregivers to share their experiential knowledge about different medical conditions and treatments to inform health technology assessments (HTAs). This presentation describes the impact of patient input on funding recommendations during the first two years of this initiative in Singapore.MethodsA literature search was conducted to identify frameworks and indicators used by different HTA agencies that could be contextualized to evaluate local patient involvement efforts. Systematic data extraction was performed by two authors to compare patient testimonials received for HTAs conducted between May 2022 and April 2024 with key information in HTA reports, minutes from committee meetings, and published HTA guidance documents to determine the impact of patient and caregiver involvement on the committees’ deliberations and subsequent funding recommendations. The impact of patient involvement on ACE staff, existing processes, and patient participation in future HTAs was also assessed through qualitative surveys.ResultsIn the first year (May 2022 to April 2023), 112 patient responses informed 11 HTAs, while 243 responses informed 16 HTAs in the subsequent year (May 2023 to April 2024). At least one testimonial was received for 84.6 percent of HTAs in the first year, increasing to 88.9 percent in the subsequent year. Patient input addressed uncertainties in the scientific evidence and helped decision-making committees understand how different conditions affect patients and their caregivers, the outcomes that matter most to patients, and the benefits and disadvantages of different treatments. In response to feedback, ACE continually evolved its processes to meet the needs of patients and to encourage broader patient participation. Industry and patient organizations also expanded their capacity so that they can meaningfully participate in future ACE HTAs.ConclusionsContinuous process improvement in response to feedback; providing patient input templates in different formats and languages to improve accessibility; and regular feedback to patient organizations on how their inputs have informed HTAs have increased patient participation, improved the legitimacy of ACE HTAs, and added value to decision-making about which health technologies should be funded in Singapore.
Publisher
Cambridge University Press
